Kulkarni Sandeep Chidambar 4

What Happened

• Sandeep Chidambar Kulkarni, CEO of Zura Bio Ltd (ZURA), received an award for 894,000 derivative shares on April 1, 2026. The grant price is listed as $0.00, indicating an option/award was granted (no cash paid at grant). This is a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-01; Filing date (Form 4): 2026-04-02 (appears timely under Form 4 rules).
• Reported transaction: Grant/Award (derivative) — 894,000 shares at $0.00.
• Shares owned after the transaction: Not specified in the provided filing details.
• Footnote: Vesting schedule — one-fourth (1/4) vests on April 1, 2027; thereafter one-twelfth (1/12) of the remaining shares vest in equal quarterly installments, subject to continuous service.
• No indication in the filing that shares were sold or that a cashless exercise occurred.

Context

• This is a typical equity compensation grant for an executive (retention/incentive), not a direct market buy or sale. The award will vest over time per the schedule noted; tax and voting rights depend on the award type and vesting/exercise mechanics.